A Phase 2 Study With Minimal Residual Disease (Mrd) Driven Adaptive Strategy In Treatment For Newly Diagnosed Multiple Myeloma With Upfront Daratumumab-Based TherapyJ Christine Ye,Philip S Boonstra,Daniel F. Boyer,Larry D. Anderson,Brea C. Lipe,Andrew Kin,Erica L. Campagnaro,Matthew J. Pianko,Moshe TalpazBLOOD(2019)引用 2|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要